Brief: FDA Approves XBiotech’s IND In Rheumatology

XBiotech

13/12/2021 13:13

Dec 13 (Reuters) - XBiotech Inc  XBIT.O :
    * FDA APPROVES XBIOTECH’S IND IN RHEUMATOLOGY
    * XBIOTECH INC - FDA'S DIVISION OF RHEUMATOLOGY HAS
AUTHORIZED CO
TO COMMENCE CLINICAL DEVELOPMENT OF NATRUNIX

Source text for Eikon:  ID:nGNE4jpD19 
Further company coverage:  XBIT.O 

 ((Reuters.Briefs@thomsonreuters.com;))